Paras Healthcare aims to increase its bed capacity by 36% to 3,011 beds by FY28 to support its upcoming ₹1,800 crore IPO. The company is focusing on North India using an asset-light expansion model to maintain financial efficiency.
Paras Healthcare Ltd has announced plans to scale its hospital bed capacity to 3,011 by March 2028. This represents a 36 percent increase from the 2,211 beds the company operated as of March 31, 2026. This expansion strategy comes as the company prepares for an Initial Public Offering (IPO) to raise ₹1,800 crore.
Focus on North India and Asset-Light Growth
The hospital chain, which operates under the Paras Health brand, is focusing its growth efforts on North India. The company targets regions where there is a high demand for specialized medical services but a limited number of hospital beds. By selecting these underserved markets, Paras Healthcare aims to improve access to advanced tertiary and quaternary care, which involves complex medical procedures and highly specialized surgery.
To manage its expansion, the company is prioritizing an asset-light model. This means that instead of buying land and constructing new buildings, Paras Healthcare enters into long-term lease agreements. For example, the upcoming 300-bed facility in Gurugram II and the 500-bed hospital in Ludhiana are both planned under such arrangements. Currently, six out of the company’s eight existing hospitals operate from leased premises, a strategy that helps reduce the amount of money spent on property acquisition.
Financial Strategy and Revenue Sources
The company is keeping a close watch on its capital spending per bed, which stood at ₹7.63 million as of March 31, 2026. By focusing on efficient hospital designs—such as compact administrative areas and shared rooms—and outsourcing non-core tasks like facility management, the firm attempts to keep its overhead costs low. Investors should note that a significant portion of the company’s revenue, approximately 74.70 percent in FY26, comes from high-acuity specialties including cardiac sciences, oncology, and neurosciences. These areas generally require advanced technology and specialized staff, which can impact profit margins.
Investor Monitorables
As the company moves toward its public listing, investors will likely track the progress of the planned facilities in Gurugram and Ludhiana. The ability to complete these projects within the estimated timelines and budgets will be important for assessing the company’s execution capabilities. Furthermore, since the company relies on leased properties and revenue-sharing agreements, its financial performance will depend on the terms of these contracts and the ability to maintain consistent demand in the chosen North Indian regions. The success of the IPO will also depend on broader market sentiment and the company’s ability to balance its aggressive expansion plans with stable cash flow.